I see the two camps -- investors and naysayers -- are retreating to their respective corners.

It was time to drag the BLA into a field and put it out of its misery. There have been hints of this for a while.

I like that mgmt called out Amarex point-blank in the PR, including the title. That's a hint about what the future holds too I suspect, i.e. Amarex is going to pay.

Before speculating about Cytodyn's future, I look forward to the call on Monday. I've long suspected there's a reason mgmt don't seem too concerned about the current share price. Let's hear what they have to say.